Positron emission tomography (PET) for cholangiocarcinoma

被引：37
作者：
Breitenstein, S. [1 ]
Apestegui, C. [1 ]
Clavien, P. -A. [1 ]
机构：
[1] Univ Zurich Hosp, Swiss HPB Ctr, Dept Surg, Zurich, Switzerland
来源：
HPB | 2008年 / 10卷 / 02期
关键词：
Cholangiocarcinoma; computed tomography (CT); positron emission tomography (PET);
D O I：
10.1080/13651820801992583
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The combination of positron emission tomography (PET) with computed tomography (PET-CT) provides simultaneous metabolic and anatomic information on tumors in the same imaging session. Sensitivity of PET/PET-CT is higher for intrahepatic (>90%) than for extrahepatic cholangiocarcinoma (CCA) (about 60%). The detection rate of distant metastasis is 100%. PET, and particularly PET-CT, improves the results and impacts on the oncological management in CCA compared with other imaging modalities. Therefore, PET-CT is recommended in the preoperative staging of intrahepatic (strength of recommendation: moderate) and extrahepatic (strength of recommendation: low) CCA.
引用
收藏
页码：120 / 121
页数：2
相关论文
共 10 条
[1]   Gallbladder cancer: Comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention [J].
Fong, Y ;
Jarnagin, W ;
Blumgart, LH .
ANNALS OF SURGERY, 2000, 232 (04) :557-566
[2]   FDG PET in the diagnosis of hilar cholangiocarcinoma [J].
Fritscher-Ravens, A ;
Bohuslavizki, KH ;
Broering, DC ;
Jenicke, L ;
Schäfer, H ;
Buchert, R ;
Rogiers, X ;
Clausen, M .
NUCLEAR MEDICINE COMMUNICATIONS, 2001, 22 (12) :1277-1285
[3]   PET diagnostic accuracy: Improvement with in-line PET-CT system: Initial results [J].
Hany, TF ;
Steinert, HC ;
Goerres, GW ;
Buck, A ;
von Schulthess, GK .
RADIOLOGY, 2002, 225 (02) :575-581
[4]   [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: Computed tomography in recurrent and metastatic cholangiocarcinoma [J].
Jadvar, Hossein ;
Henderson, Robert W. ;
Conti, Peter S. .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2007, 31 (02) :223-228
[5]   Clinical role of 18F-FDG PET for initial staging of patients with extrahepatic bile duct cancer [J].
Kato, T ;
Tsukamoto, E ;
Kuge, Y ;
Katoh, C ;
Nambu, T ;
Nobuta, A ;
Kondo, S ;
Asaka, M ;
Tamaki, N .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (08) :1047-1054
[6]   Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma [J].
Kim, YJ ;
Yun, MJ ;
Lee, WJ ;
Kim, KS ;
Lee, JD .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (11) :1467-1472
[7]   Positron emission tomography with [18F]fluoro-2-deoxy-d-glucose for diagnosis and staging of bile duct cancer [J].
Kluge, R ;
Schmidt, F ;
Caca, K ;
Barthel, H ;
Hesse, S ;
Georgi, P ;
Seese, A ;
Huster, D ;
Berr, F .
HEPATOLOGY, 2001, 33 (05) :1029-1035
[8]  
MOON CM, 2007, J GASTROENTEROL HEPA
[9]  
Morimoto Yoshikazu, 2003, J Hepatobiliary Pancreat Surg, V10, P432, DOI 10.1007/s00534-002-0842-3
[10]   Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma [J].
Petrowsky, Henrik ;
Wildbrett, Peer ;
Husarik, Daniela B. ;
Hany, Thomas F. ;
Tam, Simona ;
Jochum, Wolfram ;
Clavien, Pierre-Alain .
JOURNAL OF HEPATOLOGY, 2006, 45 (01) :43-50
1